DR. JONATHAN LEWIS WITTEN M.D. NPI 1851617732

NPI Details

DR. Jonathan Lewis Witten, M.D. is an urology in Louisville, KY with 16 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Jonathan Lewis Witten, M.D. NPI is 1851617732. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Graduation Year:2010

The provider's business location address is:

3920 S DUPONT SQ STE C
LOUISVILLE, KY
ZIP 40207-615
Phone: (812) 282-3899

The NPI 1851617732 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Automated urinalysis test (HCPCS:81003)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test by nucleic acid for herpes virus-6, amplified probe technique (HCPCS:87532)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Review by radiologist of urinary bladder and urethra images with contrast (HCPCS:74450)
• Injection procedure through bladder and urethra for x-ray imaging (HCPCS:51610)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Prostate resection (HCPCS:NAN14)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 4/16/2010 and was last updated on 9/26/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.